Rain Therapeutics Inc. (RAIN) Tops Q1 EPS by 6c

Rain Therapeutics Inc. (NASDAQ: RAIN) reported Q1 EPS of ($0.56), $0.06 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Rain Therapeutics Inc. (RAIN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank